Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 2002 Jul 15;365(Pt 2):489–496. doi: 10.1042/BJ20011798

Differential metabolism of dihomo-gamma-linolenic acid and arachidonic acid by cyclo-oxygenase-1 and cyclo-oxygenase-2: implications for cellular synthesis of prostaglandin E1 and prostaglandin E2.

Galit Levin 1, Kevin L Duffin 1, Mark G Obukowicz 1, Susan L Hummert 1, Hideji Fujiwara 1, Philip Needleman 1, Amiram Raz 1
PMCID: PMC1222686  PMID: 11939906

Abstract

Prostaglandin (PG) E(1) has been shown to possess anti-inflammatory properties and to modulate vascular reactivity. These activities are sometimes distinct from those of PGE(2), suggesting that endogenously produced PGE(1) may have some beneficial therapeutic effects compared with PGE(2). Increasing the endogenous formation of PGE(1) requires optimization of two separate processes, namely, enrichment of cellular lipids with dihomo-gamma-linolenic acid (20:3 n-6; DGLA) and effective cyclo-oxygenase-dependent oxygenation of substrate DGLA relative to arachidonic acid (AA; 20:4 n-6). DGLA and AA had similar affinities (K(m) values) and maximal reaction rates (V(max)) for cyclo-oxygenase-2 (COX-2), whereas AA was metabolized preferentially by cyclo-oxygenase-1 (COX-1). To overcome the kinetic preference of COX-1 for AA, CP-24879, a mixed Delta(5)/Delta(6) desaturase inhibitor, was used to enhance preferential accumulation of DGLA over AA in cells cultured in the presence of precursor gamma-linolenic acid (18:3 n-6). This protocol was tested in two cell lines and both yielded a DGLA/AA ratio of approx. 2.8 in the total cellular lipids. From the enzyme kinetic data, it was calculated that this ratio should offset the preference of COX-1 for AA over DGLA. PGE(1) synthesis in the DGLA-enriched cells was increased concurrent with a decline in PGE(2) formation. Nevertheless, PGE(1) synthesis was still substantially lower than that of PGE(2). It appears that employing a dietary or a combined dietary/pharmacological paradigm to augment the cellular ratio of DGLA/AA is not an effective route to enhance endogenous synthesis of PGE(1) over PGE(2), at least in cells/tissues where COX-1 predominates over COX-2.

Full Text

The Full Text of this article is available as a PDF (183.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker D. G., Krakauer K. A., Tate G., Laposata M., Zurier R. B. Suppression of human synovial cell proliferation by dihomo-gamma-linolenic acid. Arthritis Rheum. 1989 Oct;32(10):1273–1281. doi: 10.1002/anr.1780321013. [DOI] [PubMed] [Google Scholar]
  2. Banerjee N., Rosenthal M. D. High-affinity incorporation of 20-carbon polyunsaturated fatty acids by human skin fibroblasts. Biochim Biophys Acta. 1985 Jul 31;835(3):533–541. doi: 10.1016/0005-2760(85)90122-5. [DOI] [PubMed] [Google Scholar]
  3. Barre D. E., Holub B. J. The effect of borage oil consumption on the composition of individual phospholipids in human platelets. Lipids. 1992 May;27(5):315–320. doi: 10.1007/BF02536143. [DOI] [PubMed] [Google Scholar]
  4. Cameron N. E., Cotter M. A. Comparison of the effects of ascorbyl gamma-linolenic acid and gamma-linolenic acid in the correction of neurovascular deficits in diabetic rats. Diabetologia. 1996 Sep;39(9):1047–1054. doi: 10.1007/BF00400653. [DOI] [PubMed] [Google Scholar]
  5. Chapkin R. S., Somers S. D., Erickson K. L. Dietary manipulation of macrophage phospholipid classes: selective increase of dihomogammalinolenic acid. Lipids. 1988 Aug;23(8):766–770. doi: 10.1007/BF02536219. [DOI] [PubMed] [Google Scholar]
  6. Chilton-Lopez, Surette M. E., Swan D. D., Fonteh A. N., Johnson M. M., Chilton F. H. Metabolism of gammalinolenic acid in human neutrophils. J Immunol. 1996 Apr 15;156(8):2941–2947. [PubMed] [Google Scholar]
  7. Duffin K., Obukowicz M., Raz A., Shieh J. J. Electrospray/tandem mass spectrometry for quantitative analysis of lipid remodeling in essential fatty acid deficient mice. Anal Biochem. 2000 Mar 15;279(2):179–188. doi: 10.1006/abio.1999.4452. [DOI] [PubMed] [Google Scholar]
  8. Eisenbach L., Segal S., Feldman M. MHC imbalance and metastatic spread in Lewis lung carcinoma clones. Int J Cancer. 1983 Jul 15;32(1):113–120. doi: 10.1002/ijc.2910320118. [DOI] [PubMed] [Google Scholar]
  9. Fan Y. Y., Chapkin R. S. Importance of dietary gamma-linolenic acid in human health and nutrition. J Nutr. 1998 Sep;128(9):1411–1414. doi: 10.1093/jn/128.9.1411. [DOI] [PubMed] [Google Scholar]
  10. Fan Y. Y., Chapkin R. S. Mouse peritoneal macrophage prostaglandin E1 synthesis is altered by dietary gamma-linolenic acid. J Nutr. 1992 Aug;122(8):1600–1606. doi: 10.1093/jn/122.8.1600. [DOI] [PubMed] [Google Scholar]
  11. Fan Y. Y., Ramos K. S., Chapkin R. S. Dietary gamma-linolenic acid enhances mouse macrophage-derived prostaglandin E1 which inhibits vascular smooth muscle cell proliferation. J Nutr. 1997 Sep;127(9):1765–1771. doi: 10.1093/jn/127.9.1765. [DOI] [PubMed] [Google Scholar]
  12. Fan Y. Y., Ramos K. S., Chapkin R. S. Dietary gamma-linolenic acid modulates macrophage-vascular smooth muscle cell interactions. Evidence for a macrophage-derived soluble factor that downregulates DNA synthesis in smooth muscle cells. Arterioscler Thromb Vasc Biol. 1995 Sep;15(9):1397–1403. doi: 10.1161/01.atv.15.9.1397. [DOI] [PubMed] [Google Scholar]
  13. Feinstein M. B., Becker E. L., Fraser C. Thrombin, collagen and A23187 stimulated endogenous platelet arachidonate metabolism: differential inhibition by PGE1, local anesthetics and a serine-protease inhibitor. Prostaglandins. 1977;14(6):1075–1093. doi: 10.1016/0090-6980(77)90286-6. [DOI] [PubMed] [Google Scholar]
  14. Funk C. D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science. 2001 Nov 30;294(5548):1871–1875. doi: 10.1126/science.294.5548.1871. [DOI] [PubMed] [Google Scholar]
  15. Garavito R. M., DeWitt D. L. The cyclooxygenase isoforms: structural insights into the conversion of arachidonic acid to prostaglandins. Biochim Biophys Acta. 1999 Nov 23;1441(2-3):278–287. doi: 10.1016/s1388-1981(99)00147-x. [DOI] [PubMed] [Google Scholar]
  16. Gierse J. K., Hauser S. D., Creely D. P., Koboldt C., Rangwala S. H., Isakson P. C., Seibert K. Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase. Biochem J. 1995 Jan 15;305(Pt 2):479–484. doi: 10.1042/bj3050479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hart P. H., Whitty G. A., Piccoli D. S., Hamilton J. A. Control by IFN-gamma and PGE2 of TNF alpha and IL-1 production by human monocytes. Immunology. 1989 Mar;66(3):376–383. [PMC free article] [PubMed] [Google Scholar]
  18. Horrobin D. F. The regulation of prostaglandin biosynthesis: negative feedback mechanisms and the selective control of formation of I and 2 series prostaglandins: relevance to inflammation and immunity. Med Hypotheses. 1980 Jul;6(7):687–709. doi: 10.1016/0306-9877(80)90088-2. [DOI] [PubMed] [Google Scholar]
  19. Johnson M. M., Swan D. D., Surette M. E., Stegner J., Chilton T., Fonteh A. N., Chilton F. H. Dietary supplementation with gamma-linolenic acid alters fatty acid content and eicosanoid production in healthy humans. J Nutr. 1997 Aug;127(8):1435–1444. doi: 10.1093/jn/127.8.1435. [DOI] [PubMed] [Google Scholar]
  20. Kanba S., Sasakawa N., Nakaki T., Kanba K. S., Yagi G., Kato R., Richelson E. Two possibly distinct prostaglandin E1 receptors in N1E-115 clone: one mediating inositol trisphosphate formation, cyclic GMP formation, and intracellular calcium mobilization and the other mediating cyclic AMP formation. J Neurochem. 1991 Dec;57(6):2011–2015. doi: 10.1111/j.1471-4159.1991.tb06416.x. [DOI] [PubMed] [Google Scholar]
  21. Kloeze J. Relationship between chemical structure and platelet-aggregation activity of prostaglandins. Biochim Biophys Acta. 1969 Oct 28;187(3):285–292. doi: 10.1016/0005-2760(69)90001-0. [DOI] [PubMed] [Google Scholar]
  22. Knudsen P. J., Dinarello C. A., Strom T. B. Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate. J Immunol. 1986 Nov 15;137(10):3189–3194. [PubMed] [Google Scholar]
  23. Kunkel S. L., Wiggins R. C., Chensue S. W., Larrick J. Regulation of macrophage tumor necrosis factor production by prostaglandin E2. Biochem Biophys Res Commun. 1986 May 29;137(1):404–410. doi: 10.1016/0006-291x(86)91224-6. [DOI] [PubMed] [Google Scholar]
  24. Margalit A., Duffin K. L., Isakson P. C. Rapid quantitation of a large scope of eicosanoids in two models of inflammation: development of an electrospray and tandem mass spectrometry method and application to biological studies. Anal Biochem. 1996 Mar 1;235(1):73–81. doi: 10.1006/abio.1996.0093. [DOI] [PubMed] [Google Scholar]
  25. Mathias M. M., Dupont J. Quantitative relationships between dietary linoleate and prostaglandin (eicosanoid) biosynthesis. Lipids. 1985 Nov;20(11):791–801. doi: 10.1007/BF02534404. [DOI] [PubMed] [Google Scholar]
  26. Obukowicz M. G., Raz A., Pyla P. D., Rico J. G., Wendling J. M., Needleman P. Identification and characterization of a novel delta6/delta5 fatty acid desaturase inhibitor as a potential anti-inflammatory agent. Biochem Pharmacol. 1998 Apr 1;55(7):1045–1058. doi: 10.1016/s0006-2952(97)00665-5. [DOI] [PubMed] [Google Scholar]
  27. Phipps R. P., Stein S. H., Roper R. L. A new view of prostaglandin E regulation of the immune response. Immunol Today. 1991 Oct;12(10):349–352. doi: 10.1016/0167-5699(91)90064-Z. [DOI] [PubMed] [Google Scholar]
  28. Pullman-Mooar S., Laposata M., Lem D., Holman R. T., Leventhal L. J., DeMarco D., Zurier R. B. Alteration of the cellular fatty acid profile and the production of eicosanoids in human monocytes by gamma-linolenic acid. Arthritis Rheum. 1990 Oct;33(10):1526–1533. doi: 10.1002/art.1780331010. [DOI] [PubMed] [Google Scholar]
  29. Raz A., Minkes M. S., Needleman P. Endoperoxides and thromboxanes. Structural determinants for platelet aggregation and vasoconstriction. Biochim Biophys Acta. 1977 Aug 24;488(2):305–311. doi: 10.1016/0005-2760(77)90188-6. [DOI] [PubMed] [Google Scholar]
  30. Roper R. L., Phipps R. P. Prostaglandin E2 and cAMP inhibit B lymphocyte activation and simultaneously promote IgE and IgG1 synthesis. J Immunol. 1992 Nov 1;149(9):2984–2991. [PubMed] [Google Scholar]
  31. Rosenthal M. D., Brown M. E., 3rd, Jones J. E. Esterification of 8,11,14-eicosatrienoate and arachidonate into alkylacyl- and diacylglycerophosphocholine by vascular endothelial cells. Lipids. 1988 Nov;23(11):1089–1092. doi: 10.1007/BF02535658. [DOI] [PubMed] [Google Scholar]
  32. Rosenthal M. D., Garcia M. C., Sprecher H. Substrate specificity of the agonist-stimulated release of polyunsaturated fatty acids from vascular endothelial cells. Arch Biochem Biophys. 1989 Nov 1;274(2):590–600. doi: 10.1016/0003-9861(89)90474-8. [DOI] [PubMed] [Google Scholar]
  33. Rosenthal M. D., Jones J. E. Release of arachidonic acid from vascular endothelial cells: fatty acyl specificity is observed with receptor-mediated agonists and with the calcium ionophore A23187 but not with melittin. J Cell Physiol. 1988 Aug;136(2):333–340. doi: 10.1002/jcp.1041360217. [DOI] [PubMed] [Google Scholar]
  34. Rosenthal M. D., Whitehurst M. C. Selective utilization of omega 6 and omega 3 polyunsaturated fatty acids by human skin fibroblasts. J Cell Physiol. 1982 Nov;113(2):298–306. doi: 10.1002/jcp.1041130218. [DOI] [PubMed] [Google Scholar]
  35. Rubin D., Laposata M. Regulation of agonist-induced prostaglandin E1 versus prostaglandin E2 production. A mass analysis. J Biol Chem. 1991 Dec 15;266(35):23618–23623. [PubMed] [Google Scholar]
  36. Salvatori R., Guidon P. T., Jr, Rapuano B. E., Bockman R. S. Prostaglandin E1 inhibits collagenase gene expression in rabbit synoviocytes and human fibroblasts. Endocrinology. 1992 Jul;131(1):21–28. doi: 10.1210/endo.131.1.1377121. [DOI] [PubMed] [Google Scholar]
  37. Sinzinger H., Kritz H. Properties of prostaglandin E1. Circulation. 1996 Apr 1;93(7):1476–1477. [PubMed] [Google Scholar]
  38. Smith C. J., Zhang Y., Koboldt C. M., Muhammad J., Zweifel B. S., Shaffer A., Talley J. J., Masferrer J. L., Seibert K., Isakson P. C. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13313–13318. doi: 10.1073/pnas.95.22.13313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Smith W. L., DeWitt D. L., Garavito R. M. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem. 2000;69:145–182. doi: 10.1146/annurev.biochem.69.1.145. [DOI] [PubMed] [Google Scholar]
  40. Willis A. L. Nutritional and pharmacological factors in eicosanoid biology. Nutr Rev. 1981 Aug;39(8):289–301. doi: 10.1111/j.1753-4887.1981.tb06794.x. [DOI] [PubMed] [Google Scholar]
  41. Zurier R. B. Prostaglandins, immune responses, and murine lupus. Arthritis Rheum. 1982 Jul;25(7):804–809. doi: 10.1002/art.1780250718. [DOI] [PubMed] [Google Scholar]
  42. Zurier R. B., Quagliata F. Effect of prostaglandin E 1 on adjuvant arthritis. Nature. 1971 Dec 3;234(5327):304–305. doi: 10.1038/234304a0. [DOI] [PubMed] [Google Scholar]
  43. Zurier R. B., Sayadoff D. M., Torrey A. B., Rothfield N. F. Prostaglandin E treatment of NZB/NZW mice. Arthritis Rheum. 1977 Mar;20(2):723–728. doi: 10.1002/art.1780200213. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES